Group 1 - The China Securities Regulatory Commission (CSRC) has requested additional compliance information from Giant Technology regarding its equity control structure and related regulatory procedures for its overseas listing application [1][2] - Giant Technology submitted its initial public offering (IPO) application to the U.S. Securities and Exchange Commission on June 27, aiming to raise up to $9 million [1][2] - The company plans to issue 2 million shares with a price range of $4 to $5, which would give it a market capitalization of approximately $144 million based on the midpoint of the proposed range [2] Group 2 - Giant Technology provides digital marketing solutions for Chinese advertisers and operates through its entity, Chongqing Haoyu Culture Media Co., Ltd. [2] - The company utilizes its proprietary "Lucky Short Video Intelligent Data Analysis System" to evaluate the effectiveness of different visual elements in short video advertisements [2] - Giant Technology has established partnerships with leading media platforms such as Tencent and ByteDance through authorized third-party agents for advertising placements [2]

长沙晚报掌上长沙7月25日讯（全媒体记者 范宏欢） 为进一步提升企业对国际资本市场的认知，拓宽企业上市融 资途径，通过境外资本市场做大做强，7月25日，由长沙市委金融办、长沙市天心区人民政府主办，长沙市企业上 市服务中心、天心区金融事务中心、北京银行长沙分行承办的"星城投融荟"金融资本走进天心区-美股上市专题座 谈活动在北京银行举办，本次活动也是长沙市政府与北京银行合作共建"长沙企业上市北京之家"后的首场线下活 动。 长沙市委金融办副主任肖汉表示，市委金融办（市企业上市服务中心）将进一步完善企业上市支持政策，深入推 进企业上市攻坚行动，深化与纳斯达克、纽交所的战略合作，积极作为，靠前服务，努力为企业赴美上市营造更 优环境，推动更多企业成功走向国际资本市场。 天心区将以此次活动为契机，坚持以高质量发展为导向，持续聚焦企业发展需求，为企业搭建学习交流平台，开 展专题培训、融资对接活动，助力企业通过资本市场实现跨越式发展，拥抱国际市场。 活动特别邀请纳斯达克交易所、竞天公诚律师事务所等机构的专家，围绕境外上市主题，深入解读了美股上市趋 势动态，详细介绍最新监管政策情况，北京银行分享跨境投融资外汇政策及相关产品服务， ...

Core Viewpoint - The lithium battery industry is experiencing rapid growth in global markets, with Chinese companies leading the way in exports and production capacity, but they must navigate challenges in policy, market dynamics, and cost management to maintain competitive advantages. Industry Overview - China supplies 70% of battery materials and 60% of power batteries globally, showcasing its competitive edge in the lithium battery supply chain [2] - From 2020 to 2024, China's lithium battery exports are projected to grow from $15.9 billion to $61.1 billion, with a compound annual growth rate of approximately 40% [2] - Major companies like CATL and Guoxuan High-Tech have significantly increased their overseas revenues, indicating a shift from product export to capacity export [2] Market Trends - The overseas market is still in a "blue ocean" phase with high demand and limited local supply, prompting companies to establish production facilities abroad [3] - Companies such as Hunan Youneng and Tianqi Materials are announcing substantial overseas investment plans, indicating a trend of industry collaboration in international expansion [3] Investment and Financing - The trend of overseas listings is gaining momentum, with companies like Guoxuan High-Tech and Gree Energy issuing GDRs to support global expansion [5] - Hong Kong has become a preferred listing destination for many lithium battery companies, driven by supportive policies and the need for funding [6] Production Capacity and Profitability - Several leading lithium battery companies have reported full order books and are beginning to achieve profitability from their overseas factories [9] - CATL's factory in Germany has reached profitability, and its Hungarian facility is expected to follow suit, benefiting from lessons learned in Germany [9] Localized Operations - Companies are focusing on localizing their operations to enhance customer loyalty and reduce trade barriers [4] - The establishment of joint ventures and acquisitions is a strategy employed by companies like EVE Energy and Rongbai Technology to integrate into local markets [12] Strategic Considerations - The lithium battery industry must consider various factors such as downstream order demand, policy changes, and local operational capabilities when expanding internationally [11] - Companies are investing in training and development to prepare their teams for overseas operations, ensuring successful project implementation [11]

Group 1 - The company held its 17th temporary board meeting on July 21, 2025, with all 7 directors present, including independent directors participating via communication [2][4] - The board approved the proposal to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy and competitiveness [3][6] - The proposal requires approval from the shareholders' meeting [5] Group 2 - The H-shares will be publicly offered on the main board of the Hong Kong Stock Exchange, with a nominal value of RMB 1.00 per share [7][9] - The issuance will target global investors, including public investors in Hong Kong and qualified domestic institutional investors [13] - The issuance method will include both public offering in Hong Kong and international placement [15] Group 3 - The proposed issuance scale is up to 10% of the total share capital post-issuance, with an option for an additional 15% through an over-allotment option [17] - The final pricing will be determined based on market conditions and investor demand [20] - The distribution of shares will follow a mechanism that considers the number of valid applications received during the public offering [22] Group 4 - The company plans to use the funds raised for capacity expansion, enhancing production infrastructure, and general working capital [28] - The board's resolutions regarding the issuance will remain valid for 24 months from the date of approval by the shareholders' meeting [30] - The board is authorized to handle all matters related to the issuance and listing of H-shares [32] Group 5 - The company will register as a "non-Hong Kong company" under Hong Kong law to facilitate the listing process [60] - The board approved the appointment of independent directors to enhance governance in line with listing requirements [63] - The company will revise its articles of association and related rules to comply with the new listing regulations [73]

Core Viewpoint - The company plans to issue H shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy and competitiveness [1][2]. Meeting Details - The 15th meeting of the 9th Supervisory Board was held on July 21, 2025, with all three supervisors present, and the meeting complied with relevant laws and regulations [1][2]. H Share Issuance Proposal - The Supervisory Board approved the proposal for issuing H shares and listing on the Hong Kong Stock Exchange, which requires further approval from the shareholders' meeting [2][3]. - The H shares will be publicly offered on the Hong Kong Stock Exchange and will have a nominal value of RMB 1.00 per share [2][3]. Issuance and Listing Plan - The issuance will be conducted globally, targeting both Hong Kong public investors and international investors, including qualified domestic institutional investors [3][4]. - The final number of H shares to be issued will not exceed 10% of the total share capital post-issuance, with an option for an additional 15% through an over-allotment option [5][6]. Use of Proceeds - The funds raised from the issuance will be used for capacity expansion, enhancing production infrastructure, global R&D, and general working capital [8][9]. Shareholder Rights and Profit Distribution - The retained earnings before the issuance will be shared among new and existing shareholders based on their shareholding ratios post-issuance [10][11]. Insurance and Audit Arrangements - The company plans to purchase liability insurance for directors and senior management and appoint an auditing firm for the issuance process [11][12].

Core Viewpoint - The article highlights the recent developments of Zhejiang Xinwanda Power Battery Co., including the acceptance of the environmental assessment for the second phase of its production base in Yiwu, which is part of a larger investment strategy to expand battery production capacity and enhance global presence [1][3][4]. Group 1: Company Developments - Zhejiang Xinwanda has signed an agreement with Yiwu City in September 2022 for a total investment of 21.3 billion yuan, aiming to establish a production base with an annual capacity of 50GWh for power and energy storage batteries [1]. - The first phase of the project involves an investment of approximately 12.8 billion yuan to build production lines for 30GWh of battery cells, modules, PACK, and battery systems, while the second phase will invest around 8.5 billion yuan for an additional 20GWh capacity [1]. - The company was established on December 16, 2022, with an ownership structure of 80% by Xinwanda Holdings and 20% by Zhejiang Yixin Power Battery Co., which is backed by state-owned enterprises in Yiwu [1]. Group 2: Production and Global Expansion - Xinwanda has established production bases in various locations including Nanjing, Nanchang, Huizhou, Zaozhuang, Shifang, Yichang, and Yiwu [2]. - The company is actively pursuing a global strategy, with existing bases in India, Vietnam, and Morocco, and plans to accelerate its international expansion in 2024, including projects in Vietnam, Hungary, and Thailand [3]. - The Thailand project, approved in March 2023, involves an investment of over 1 billion USD (approximately 716.6 million yuan) to produce batteries for electric vehicles and energy storage systems [4]. Group 3: Market Positioning - Xinwanda's planned issuance of H-shares and listing on the Hong Kong Stock Exchange is expected to enhance its recognition in global capital markets and support its long-term development strategy [4].

Core Viewpoint - The company, Shantui Construction Machinery Co., Ltd. (stock code: 000680), has announced its plan to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its global development and capital operation capabilities [1] Group 1: H-Share Issuance - The company plans to issue H-shares to meet its global development needs and improve its brand recognition and competitiveness [1] - The pricing of the H-shares will be determined through a market-oriented pricing method [1] - The company has approved several resolutions related to the H-share issuance, including the use of raised funds and the appointment of an auditing firm for the H-share issuance [1] Group 2: Corporate Governance - The resolutions regarding the H-share issuance and related matters will be submitted for approval at the company's shareholders' meeting [1] - The company has also reviewed the report on the use of previously raised funds and the plan for the use of funds from the H-share issuance [1]

Group 1 - The core viewpoint of the article is that Kangzheng Pharmaceutical (00867.HK) has announced a secondary listing on the Singapore Exchange, which aims to enhance its business presence in Southeast Asia and tap into the mature investor market in Singapore [1] - The company emphasizes that Southeast Asia, with a population of nearly 700 million, is experiencing rising pharmaceutical demand due to economic growth, an expanding middle class, aging populations, and an increase in non-communicable diseases [1] - Kangzheng Pharmaceutical has established Singapore as its regional headquarters for Southeast Asia and the Middle East [1] Group 2 - Kangzheng Pharmaceutical was listed in Hong Kong on September 28, 2010, and focuses on specialized fields such as cardiovascular, central nervous system, digestive, and ophthalmology [1] - The company currently has five innovative drugs in the commercialization stage, including "Meitai Tong" for psoriasis and "Laifulan" for methylene blue enteric-coated sustained-release tablets, along with three drugs entering national procurement [1] - As of the latest trading session, Kangzheng Pharmaceutical's stock price was HK$12.94, with a total market capitalization of HK$31.567 billion [2]

Group 1 - The China Securities Regulatory Commission (CSRC) has requested Dazhu CNC to provide supplementary materials regarding its compliance with foreign investment policies before and after its planned overseas listing [1] - Dazhu CNC has submitted a listing application to the Hong Kong Stock Exchange, with China International Capital Corporation (CICC) as the sole sponsor [1] - The company is a leading provider of PCB (Printed Circuit Board) specialized production equipment solutions, with over 20 years of experience in the industry [1] Group 2 - Dazhu CNC's revenue for the fiscal years 2022, 2023, and 2024 was approximately 2.786 billion, 1.634 billion, and 3.343 billion RMB respectively [2] - The net profit for the same periods was approximately 432 million, 136 million, and 300 million RMB respectively [2]

Group 1 - The China Securities Regulatory Commission (CSRC) has requested supplementary materials from Muyuan Foods Co., Ltd. regarding its compliance with foreign investment policies and the use of funds raised for global expansion [1] - Muyuan Foods is a global leader in the pig farming industry, covering the entire supply chain from breeding to meat processing [2] - The company's global market share in pig production has increased from 2.6% in 2021 to 5.6% in 2024, surpassing the combined market share of its second to fourth competitors [2] Group 2 - From 2014 to 2024, Muyuan Foods achieved a compound annual growth rate (CAGR) of 48.7% in total revenue, ranking first among the top ten listed pork companies globally in terms of revenue growth [2][3] - The company's net profit CAGR during the same period reached 72.7%, with an average net profit margin of 19.0%, making it the only company among the top ten pork companies to maintain an average net profit margin above 15% [3] - The global pork consumption is projected to grow from 95.2 million tons in 2020 to 115.3 million tons in 2024, with a CAGR of 4.9%, indicating significant market potential for the industry [3]